首页> 外文期刊>Current opinion in drug discovery & development >RNA interference for studying the molecular basis of neuropsychiatric disorders.
【24h】

RNA interference for studying the molecular basis of neuropsychiatric disorders.

机译:RNA干扰用于研究神经精神疾病的分子基础。

获取原文
获取原文并翻译 | 示例
           

摘要

RNA interference (RNAi) is a universal and evolutionarily conserved phenomenon of post-transcriptional gene silencing by sequence-specific mRNA degradation, which is triggered by short double-stranded RNA. This mechanism can be efficiently induced both in vitro and in vivo by expressing target-complementary short hairpin RNA (shRNA) from non-viral and viral vectors, or by the application of short interfering RNA (siRNA). The design of highly selective and efficacious siRNA and shRNA has become commonplace, owing to continuous progress in modeling, bioinformatics and chemistry. Thus, RNAi is attractive for use in functional genomics, target and pathway validation and, potentially, human therapeutics. This review highlights recent findings in the field of RNAi with emphasis on neuropsychiatric aspects.
机译:RNA干扰(RNAi)是转录后基因沉默的一种普遍且在进化上保守的现象,该现象是由短双链RNA触发的序列特异性mRNA降解引起的。通过从非病毒和病毒载体表达靶标互补的短发夹RNA(shRNA),或通过应用短干扰RNA(siRNA),可以有效地在体内和体外诱导该机制。由于建模,生物信息学和化学领域的不断发展,高选择性和有效的siRNA和shRNA的设计已变得司空见惯。因此,RNAi在功能基因组学,靶标和途径验证以及潜在的人类疗法中具有吸引力。这篇综述突出了RNAi领域的最新发现,重点是神经精神方面。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号